Business Wire Industry News

Wednesday, October 16, 2019

Zymeworks Appoints Chief People Officer

VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced the appointment of Kathryn O’Driscoll to the executive team as Chief People Officer (CPO). Ms. O'Driscoll brings over 20 years of experience as an executive-level human resources leader across large global organizations in the technology and non-profit sectors. In her new role as Zymeworks’ CPO, she will be responsible for

Wednesday, October 16, 2019

Halo Labs Announces Closing of Second Tranche For Completion Of Aggregate CAD $4 Million Private Placement

TORONTO--(BUSINESS WIRE)--Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that, further to the Company’s press releases of October 7, 2019 and October 11, 2019, Halo has closed a second tranche of the previously announced non-brokered increased private placement of Halo common shares (the “Offering”) at a price of CAD $0.31 per share for additional gross proceeds of approximately CAD $1 million (the “Second Tranche”). The Company previous

Wednesday, October 16, 2019

Announcement of New President and Chief Executive Officer for Ag-West Bio

SASKATOON, Saskatchewan--(BUSINESS WIRE)-- #Saskatchewan--The Board of Directors of Ag-West Bio Inc. is pleased to announce the appointment of Karen Churchill as the organization’s next president and chief executive officer. Churchill brings to the position a wealth of knowledge and an array of experiences in the agriculture industry, on a provincial, national and global level. She will join Ag-West Bio on November 18, 2019. Churchill holds a PhD in Food Science, with a focus on cereal chemistry, from the Univ

Wednesday, October 16, 2019

/ C O R R E C T I O N From Source – IMV Inc /

DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--In the news release issued on October 11, IMV announced that company management presentation at the BIO Investor Forum is scheduled on October 23 at 5:00 PM PST (8:00 PM EST). Please, note that the presentation and webcast are scheduled on October 23 at 2:00 PM PST (5:00 PM EST). The corrected release follows: IMV Inc. to Present at Upcoming Investor Conference IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology company, today announced th

Wednesday, October 16, 2019

REPEAT/Halo Labs Announces Partnership Agreement with Greeny.com

TORONTO--(BUSINESS WIRE)--Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announces a partnership agreement between Dispensary Track, a Halo Canadian subsidiary, and Greeny.com, a one-stop online marketplace for CBD-based products. Halo has selected Greeny.com to be the CBD products store featured on Dispensary Track’s phone and tablet applications. The Company recently closed on the acquisition of Dispensary Track, a platform that allows customers to ele

Tuesday, October 15, 2019

Halo Labs Announces Partnership Agreement with Greeny.com

TORONTO--(BUSINESS WIRE)--Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) today announces a partnership agreement between Dispensary Track, a Halo Canadian subsidiary, and Greeny.com, a one-stop online marketplace for CBD-based products. Halo has selected Greeny.com to be the CBD products store featured on Dispensary Track’s phone and tablet applications. The Company recently closed on the acquisition of Dispensary Track, a platform that allows customers to ele

Tuesday, October 15, 2019

REPEAT/Halo Announces Closing of the Previously Announced Private Placement For CAD $3 Million Which is Anticipated to Be Upsized To CAD $4 Million Due to Increased Demand and Completion of Acquisition of Cannpos Services Corp.

TORONTO--(BUSINESS WIRE)--Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that, further to the press release dated October 7, 2019 (the “October 7 Press Release”), it has closed the previously announced non-brokered private placement of Halo common shares at a price of CAD $0.31 per share for aggregate gross proceeds of CAD $3 million (the “Private Placement”). Due to increase investor interest, the Company anticipates that the Private Pl

Tuesday, October 15, 2019

Avivagen Announces Proposed Extension of Warrants

OTTAWA, Ontario--(BUSINESS WIRE)--Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely support immune function, promote general health and performance, today announced that it will be requesting approval from the TSX Venture Exchange for the extension of the expiration date of warrants exercisable to purchase 1,163,738 common shares at $1.00 pe

Monday, October 14, 2019

BIONIK Laboratories Partners with Intelliware Development to Provide Seamless Connectivity Between InMotionTM Robotic Devices and Hospital Information Systems

TORONTO & BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB:BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today announced it has partnered with Intelliware Development to meet the data connectivity needs of hospitals and healthcare facilities utilizing sensored technologies nationwide. Intelliware Development, a leading custom sof

Friday, October 11, 2019

Halo Announces Closing of the Previously Announced Private Placement For CAD $3 Million Which is Anticipated to Be Upsized To CAD $4 Million Due to Increased Demand and Completion of Acquisition of Cannpos Services Corp.

TORONTO--(BUSINESS WIRE)--Halo Labs Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that, further to the press release dated October 7, 2019 (the “October 7 Press Release”), it has closed the previously announced non-brokered private placement of Halo common shares at a price of CAD $0.31 per share for aggregate gross proceeds of CAD $3 million (the “Private Placement”). Due to increase investor interest, the Company anticipates that the Private Pl

Friday, October 11, 2019

FSD Pharma Appoints Former Member of U.S. Congress to its Board of Directors, Announces Share Consolidation

TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD" or the "Company") today announced the appointment of former U.S. congressman Stephen Buyer to the Company’s Board of Directors. The Company also announced that it will complete a consolidation of its class A multiple voting shares ("Class A Shares") and its class B subordinate voting shares ("Class B Shares" and collectively with the Class A Shares, the "FSD Shares"), each on a 1 to 201 basis (the "Consolidat

Friday, October 11, 2019

IMV Inc. to Present at Upcoming Investor Conference

DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology company, today announced that company management will be attending the BIO Investor Forum to be held on October 22-23 at the Westin St. Francis, San Francisco. BIO Investor Forum and Webcast Oct. 23 5:00 PM PST A live webcast of this presentation will be available under “Events, Webcasts and Presentations” in the investors section of IMV’s website and a replay will be available approximat